Saggar Rajeev
Chief Medical Officer
Saggar Rajeev has filed 9 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$11.7M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| LQDA | Chief Medical Officer | Sale | 29,534 | $2.3M | Aug 19 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 50,000 | $3.7M | Aug 19 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 9,926 | $710K | Jul 15 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 9,220 | $354K | Apr 14 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 35,365 | $1.3M | Mar 17 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 21,142 | $791K | Jan 13 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 71,381 | $1.9M | Nov 7 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 5,327 | $125K | Oct 15 | SEC ↗ | |
| LQDA | Chief Medical Officer | Sale | 20,000 | $557K | Sep 2 | SEC ↗ |